AR055108A1 - Derivados de fenilpiridina, su obtencion y su utilizacion en composiciones farmaceuticas para el tratamiento del cancer. - Google Patents
Derivados de fenilpiridina, su obtencion y su utilizacion en composiciones farmaceuticas para el tratamiento del cancer.Info
- Publication number
- AR055108A1 AR055108A1 ARP060103369A ARP060103369A AR055108A1 AR 055108 A1 AR055108 A1 AR 055108A1 AR P060103369 A ARP060103369 A AR P060103369A AR P060103369 A ARP060103369 A AR P060103369A AR 055108 A1 AR055108 A1 AR 055108A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- obtaining
- cancer
- alkyl
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Obtencion de los compuestos recién mencionados, las composiciones farmacéuticas que los contienen y su fabricacion, así como el uso de los compuestos recién mencionados para el control o la prevencion de enfermedades, tales como el cáncer. Reivindicacion 1: Los compuestos de la formula (1) en la que R1 es halogeno, alquilo, alcoxi, alquilo halogenado o alcoxi halogenado; R2 es H o halogeno; R3 es H o alquilo C1-3; R4 es H o alquilo C1-3; W es -CH2-, -O-, -S-, -S(O)- o -S(O)2- ; y todas las sales farmacéuticamente aceptables de los mismos. Reivindicacion 6: Un proceso para la obtencion de los compuestos de la formula (1) segun la reivindicacion 1, en el que (a) se hace reaccionar el compuesto de la formula (2) en la que R1, R2 y R3 tienen los significados definidos para la anterior formula (1) en la reivindicacion 1, con un compuesto de la formula (3) en la que R4 y W tienen los significados definidos para la anterior formula (1) en la reivindicacion 1, para obtener el correspondiente compuesto de la formula (1); (b) se aísla dicho compuesto de la mezcla reaccionante y (c) si se desea, se convierte en una sal farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05016956 | 2005-08-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR055108A1 true AR055108A1 (es) | 2007-08-08 |
Family
ID=35746007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060103369A AR055108A1 (es) | 2005-08-04 | 2006-08-02 | Derivados de fenilpiridina, su obtencion y su utilizacion en composiciones farmaceuticas para el tratamiento del cancer. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7429605B2 (es) |
| EP (1) | EP1912969A1 (es) |
| JP (1) | JP2009503007A (es) |
| KR (1) | KR20080027914A (es) |
| CN (1) | CN101213186A (es) |
| AR (1) | AR055108A1 (es) |
| AU (1) | AU2006278853A1 (es) |
| BR (1) | BRPI0614101A2 (es) |
| CA (1) | CA2615695A1 (es) |
| IL (1) | IL188185A0 (es) |
| MX (1) | MX2008001412A (es) |
| TW (1) | TW200738680A (es) |
| WO (1) | WO2007017169A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006076575A2 (en) * | 2005-01-13 | 2006-07-20 | Bristol-Myers Squibb Company | Substituted biaryl compounds as factor xia inhibitors |
| KR102613433B1 (ko) | 2017-10-11 | 2023-12-13 | 주식회사 대웅제약 | 신규한 페닐피리딘 유도체 및 이를 포함하는 약학 조성물 |
| CA2995617A1 (en) | 2017-11-03 | 2019-05-03 | Universite De Montreal | Heterocyclic mitochondrial activity inhibitors and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL84944A (en) | 1987-01-19 | 1992-02-16 | Ici Plc | Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation |
| AU3461697A (en) | 1996-07-19 | 1998-02-10 | Takeda Chemical Industries Ltd. | Heterocyclic compounds, their production and use |
| PE20011178A1 (es) | 2000-04-07 | 2001-11-19 | Takeda Chemical Industries Ltd | Compuestos heterociclicos y su produccion |
| KR20030013360A (ko) | 2000-07-19 | 2003-02-14 | 다케다 야쿠힌 고교 가부시키가이샤 | 1-치환-1,2,3-트리아졸 유도체의 제조 방법 |
| US6984653B2 (en) | 2001-10-05 | 2006-01-10 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof |
| WO2003059907A1 (fr) | 2002-01-17 | 2003-07-24 | Takeda Chemical Industries, Ltd. | Composes heterocycliques azotes : procede de preparation et d'utilisation |
| JP2005526723A (ja) | 2002-02-15 | 2005-09-08 | グラクソ グループ リミテッド | バニロイド受容体モジュレーター |
| WO2004007439A1 (ja) | 2002-07-10 | 2004-01-22 | Sumitomo Pharmaceuticals Co., Ltd. | ビアリール誘導体 |
| TW200505913A (en) | 2003-03-28 | 2005-02-16 | Hoffmann La Roche | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
| CA2543249C (en) | 2003-11-05 | 2012-08-07 | F. Hoffmann-La Roche Ag | Phenyl derivatives as ppar agonists |
-
2006
- 2006-08-01 US US11/497,145 patent/US7429605B2/en not_active Expired - Fee Related
- 2006-08-01 TW TW095128160A patent/TW200738680A/zh unknown
- 2006-08-02 JP JP2008524431A patent/JP2009503007A/ja active Pending
- 2006-08-02 KR KR1020087002761A patent/KR20080027914A/ko not_active Application Discontinuation
- 2006-08-02 BR BRPI0614101-3A patent/BRPI0614101A2/pt not_active Application Discontinuation
- 2006-08-02 AU AU2006278853A patent/AU2006278853A1/en not_active Abandoned
- 2006-08-02 MX MX2008001412A patent/MX2008001412A/es not_active Application Discontinuation
- 2006-08-02 CA CA002615695A patent/CA2615695A1/en not_active Abandoned
- 2006-08-02 EP EP06776560A patent/EP1912969A1/en not_active Withdrawn
- 2006-08-02 AR ARP060103369A patent/AR055108A1/es not_active Application Discontinuation
- 2006-08-02 CN CNA2006800235335A patent/CN101213186A/zh active Pending
- 2006-08-02 WO PCT/EP2006/007646 patent/WO2007017169A1/en active Application Filing
-
2007
- 2007-12-17 IL IL188185A patent/IL188185A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2615695A1 (en) | 2007-02-15 |
| AU2006278853A1 (en) | 2007-02-15 |
| KR20080027914A (ko) | 2008-03-28 |
| EP1912969A1 (en) | 2008-04-23 |
| US7429605B2 (en) | 2008-09-30 |
| CN101213186A (zh) | 2008-07-02 |
| MX2008001412A (es) | 2008-04-04 |
| US20070032530A1 (en) | 2007-02-08 |
| JP2009503007A (ja) | 2009-01-29 |
| WO2007017169A1 (en) | 2007-02-15 |
| TW200738680A (en) | 2007-10-16 |
| BRPI0614101A2 (pt) | 2011-03-09 |
| IL188185A0 (en) | 2008-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY30411A1 (es) | Derivados sustituidos del acetato de 2,3,4,-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones | |
| CY1110952T1 (el) | Παραγωγα κινουκλιδινης και η χρηση αυτων ως μουσκαρινικοι ανταγωνιστες υποδοχεων μ3 | |
| DOP2006000169A (es) | Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
| UY29919A1 (es) | Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones | |
| ECSP066383A (es) | Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias | |
| UY30025A1 (es) | Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
| UY30414A1 (es) | Metano sulfonatos, propano-1-sulfonatos y ciclopropan sulfonatos sustituidos con [2,3,4,8-tetrahidroimidazo-[1,5-al-pirimidin-8-il]-fenilo, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
| PA8547701A1 (es) | Nucleosidos 4 substituidos. | |
| ATE440834T1 (de) | Substituierte arylaminderivate und verwendungsverfahren | |
| NO20055590L (no) | Kinaseinhiberende fosfonatanaloger | |
| BRPI0817096A8 (pt) | Análogo de tiazolidinodiona e composição farmacêutica que o compreende | |
| ATE473975T1 (de) | Chemische verbindungen | |
| ATE398613T1 (de) | Chemische verbindungen | |
| UY30407A1 (es) | Derivados de [2,3,4,8-tetrahidroimidazo-[1,5-a]-pirimidin-8-il]-fenil sulfonatos sustituidos, composiciones farmacéuticas y aplicaciones. | |
| ECSP088099A (es) | Nuevos derivados de la 2-azetidinona para el tratamiento de enfermedades hiperlipidémicas | |
| BRPI0513433A (pt) | derivados de hidantoìna para o tratamento de distúrbios inflamatórios | |
| AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| BRPI0607600A2 (pt) | derivados de 4-oxoquinazolin-3-il-benzamida para o tratamento de doenças relacionadas com citocina | |
| MX2009003874A (es) | Derivados de espiro-oxindol triciclicos y sus usos como agentes terapeuticos. | |
| UY30274A1 (es) | Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones | |
| AR052938A1 (es) | Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos, composiciones farmaceuticas que los comprenden y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por el receptor vr1 | |
| DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
| AR056574A1 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| ATE482955T1 (de) | Azabicyclooctan-3-onderivate und deren verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |